Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma

NCT03291314 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma (WHO-Grade IV Glioma)

Interventions

DRUG: Axitinib
DRUG: Avelumab

Sponsor

Universitair Ziekenhuis Brussel